Home PhagoMed

PhagoMed

In operation
Equity Financing
Phage Therapy Developer
Basic
Enterprise Profile

Basic Information

PhagoMed Biopharma Develops Phage Therapies as Antibiotic Alternatives to Address the Urgent Medical Need for New Antibiotics. The Platform Focuses on Developing Human Therapeutic Applications of Phages and Phage-Derived Proteins Related to Urinary Tract Infections and Bacterial Vaginosis, Enabling Patients to Access Antibiotics.
PhagoMed Biopharma GmbH
Austria
unclear
November 23, 2017
contact@phagomed.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology Biotechnology
Concept
Urinary Tract Infection